Pharmacy Management
Prescription drugs are the fastest growing component of healthcare costs. These costs can be prohibitive, requiring employers to change plan designs and shift even more cost to their employees. This is particularly true for specialty medications that typically represent 50% of drug spend from just 1-2% of drug utilizers.
Unfortunately, many employers don’t have the purchasing power or market leverage to negotiate better pricing. It’s also challenging for employers to identify and access money saving opportunities.
Our Alera Group Pharmacy Solutions practice has a dedicated team of experienced, in-house Pharmacy Benefits Management experts. They offer a full range of pharmacy consulting services, including:
- Prescription drug program evaluations for clients of all sizes and industries
- Comprehensive RFP management renewal, market check and RFI
- PBM contract review and negotiation
- Consultative support to identify and deploy unique cost-mitigation for specialty drug solutions
- Data analytics that enable precise financial and clinical pharmacy benefits consulting and reporting, maximizing the plan value and employee dollars
- All forms of pharmacy benefits auditing, including PBM contract pricing, plan design and clinical
- On-going risk management and cost containment under our Rx Concierge Program
With Alera Group, you have a local partner and a team of experts you can rely on to help you manage pharmacy costs and improve your outcomes today and in the future.
Our Alera Group Pharmacy Solutions experts are backed by leading-edge tools and strategic solutions focused on meeting the needs and expectations of our clients through every stage of the pharmacy process.
Control pharmacy costs
From procurement to prescriptions.
EXPERT EDUCATION
Events and Webinars
Employee Benefits
Preparing for Open Enrollment: How to Engage and Educate Your Employees on Their Total Benefits Package
In this session, our experts will share guidance on setting yourself up for success during Open Enrollment.
August 21, 2025 at 01:00 pm CT | Virtual
Sign Up
THOUGHT LEADERSHIP
Insights
Employee Benefits
Legal Alert: IRS Issues Affordability Percentage Adjustment for 2026
The Internal Revenue Service (IRS) has released Rev. Proc. 2025-25, which contains the inflation adjusted amounts for 2026 used to determine whether employer-sponsored coverage is “affordable” for purposes of the Affordable Care Act’s (ACA) employer shared responsibility provisions and premium tax credit program.
July 23, 2025
Find out more
Employee Benefits
Legal Alert: Enforcement of the HIPAA Reproductive Health Care Privacy Rule Vacated Nationwide
On June 18, 2025, a federal district court in Texas vacated a significant portion of the HIPAA Privacy Rule to Support Reproductive Health Care Privacy (“Final Rule”), which was implemented on April 24, 2024, on a nationwide basis. The Final Rule, which was implemented in response to the U.S. Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization (effectively overturning Roe v. Wade), was intended to protect the ability of individuals to receive reproductive health care when the care is provided lawfully under the circumstances without risk of an individual’s identity or health information being disclosed for purposes of state criminal, civil or administrative investigations (or for imposing liability related to lawfully providing or obtaining reproductive healthcare).
July 21, 2025
Find out more Employee Benefits
Legal Alert: RxDC Reporting Due June 1
Reminder: RxDC Reporting Due June 1
With the 2023 reference year RxDC reporting deadline approaching soon, plan sponsors should familiarize themselves with recent updates to the RxDC Reporting Instructions.
March 27, 2024
Find out more Employee Benefits
Webinar: Weight-Loss Drugs and Group Health Plans | Alera Group
Rising pharmacy costs are among the chief drivers of healthcare expenses for employers and employees, thanks largely to a surge in use of drugs you’ve seen advertised in those ubiquitous commercials. Given the cost of such drugs and their mixed record of success, employers and employees should exercise caution.
February 6, 2024
Find out more